Hepatitis C Treatment Uptake - Peer Insights on Barriers and Motivators to Direct Acting Antiviral (DAA) Treatment Uptake (Broadsheet No.3)

The knowledge and experience of people who inject drugs within peer programs is a vital asset for strategies for the scale-up of direct-acting antiviral treatment among people who inject drugs. This study is focused on translating these ‘real time’ peer insights into resources that support policy and programs to tailor to the needs of communities of people who inject. This tailoring is critical to achieving the goal of eliminating hepatitis C. This report is the third and final in a series of three broadsheet reports. In this broadsheet, peer workersand peer volunteers located in country and regional areas inVictoria, WA and NSW, shared their insights on hepatitis Ctreatment uptake among their networks.